Lee, Elizabeth K <br/><br/>
Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer.  [electronic resource] 

 -  Gynecologic oncology reports  Aug 2019 
 - 118-122 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2352-5789 
<br/><br/><label>Standard No.: </label>10.1016/j.gore.2019.07.010  doi